文献速递肺外科

新辅助治疗后非小细胞肺癌机器人 vs 电视辅助胸腔镜手术的围术期结局

Perioperative Outcomes of Robotic- vs Video-Assisted Thoracoscopic Surgery in Non-Small Cell Lung Cancer After Neoadjuvant Therapy.
PubMed 文献 · Ann Thorac Surg · 2025-12-26

该回顾性研究纳入939例新辅助治疗后NSCLC患者(VATS 816例,RATS 123例),经1:2倾向性评分匹配后比较围术期结局。匹配后RATS组中转开胸率更低、淋巴结清扫更充分、出血量更少、手术时间更短、胸管留置时间更短,持续性漏气>7天更少;袖状肺叶切除亚组中RATS进一步缩短手术时间和胸管留置时间。多因素回归显示手术时间延长和全肺切除独立预测并发症。

要点

  • 新辅助治疗后NSCLC,RATS较VATS中转开胸率更低、淋巴结清扫更充分。
  • RATS组出血量、手术时间、胸管留置时间更短,持续性漏气>7天更少。
  • 袖状肺叶切除亚组中RATS进一步缩短手术时间和胸管留置时间。

核心结论

  • 新辅助治疗后NSCLC患者中,RATS较VATS围术期结局更有利,尤其在袖状肺叶切除中可显著缩短手术时间和胸管留置时间,提示其复杂切除的潜在应用价值。

研究设计与样本

  • 回顾性分析939例新辅助治疗后NSCLC患者(2021-2023年),其中VATS 816例、RATS 123例。
  • 采用1:2倾向性评分匹配建立平衡队列,匹配后VATS 246例、RATS 123例。
  • 比较人口学特征、新辅助治疗疗效和围术期结局,亚组分析评估RATS在袖状肺叶切除中的获益,logistic回归识别术后并发症危险因素。

主要发现

  • 匹配后RATS组中转开胸率3.1% vs 8.9%(P = .044)。
  • RATS组淋巴结清扫站数7(IQR 6-8)vs 5(IQR 5-6.25),清扫数目18(IQR 14-26)vs 14(IQR 10-20),均P < .001。
  • RATS组出血量50 mL(IQR 50-100 mL)vs 50 mL(IQR 50-100 mL),P = .048;手术时间124分钟(IQR 110-170分钟)vs 130分钟(IQR 117-184分钟),P = .041;胸管留置时间4天(IQR 3-5天)vs 5天(IQR 3-6天),P = .002。
  • RATS组持续性漏气>7天发生率1.6% vs 7.7%(P = .017)。
  • 袖状肺叶切除亚组中,RATS手术时间150分钟(110-200.5分钟)vs 197.5分钟(147.25-238.5分钟),P = .003;胸管留置时间4天(3-6天)vs 5天(4-6天),P = .014。

临床怎么用

  • 对新辅助治疗后NSCLC,尤其需袖状肺叶切除的复杂病例,RATS可作为减少中转开胸、改善围术期恢复的术式选择。
  • 关注手术时间和全肺切除等独立并发症危险因素,优化围术期管理。

局限性

  • 回顾性研究设计,存在选择偏倚可能。
  • RATS样本量相对较小(匹配后123例),亚组分析结果需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study compared perioperative outcomes between robotic-assisted thoracoscopic surgery (RATS) and video-assisted thoracoscopic surgery (VATS) in non-small cell lung cancer (NSCLC) patients after neoadjuvant therapy. METHODS: We retrospectively analyzed 939 NSCLC patients (2021-2023), including 816 VATS and 123 RATS cases. A 1:2 propensity score-matching method was adopted to create a balanced cohort, including 246 with VATS and 123 with RATS. Demographic characteristics, neoadjuvant therapy efficacy, and perioperative outcomes were compared. Subgroup analysis evaluated RATS benefits in sleeve lobectomy, and logistic regression identified risk factors for postoperative complications. RESULTS: After matching, RATS showed lower thoracotomy conversion rates (3.1% vs 8.9%, P = .044), greater lymph node dissection (stations: 7 [interquartile range {IQR}, 6-8] vs 5 [IQR, 5-6.25]; numbers: 18 [IQR, 14-26] vs 14 [IQR, 10-20]; both P < .001), reduced blood loss (50 mL [IQR, 50-100 mL] vs 50 mL [IQR, 50-100 mL], P = .048), shorter operative time (124 minutes [IQR, 110-170 minutes] vs 130 minutes [IQR, 117-184 minutes], P = .041), and shorter chest tube duration (4 days [IQR, 3-5 days] vs 5 days [IQR, 3-6 days], P = .002). Persistent air leak >7 days was less frequent with RATS (1.6% vs 7.7%, P = .017). In sleeve lobectomy, RATS further reduced operative time (150 minutes [110-200.5 minutes] vs 197.5 minutes [147.25-238.5 minutes], P = .003) and chest tube duration (4 days [3-6 days] vs 5 days [4-6 days], P = .014). Multivariable logistic regression analyze shows prolonged operative time (odds ratio, 1.014; 95% CI, 1.008-1.020; P < .001) and pneumonectomy (odds ratio, 4.866; 95% CI 1.236-19.158; P = .024) independently predicted complications. CONCLUSIONS: RATS is associated with more favorable perioperative outcomes compared with VATS in NSCLC after neoadjuvant therapy, especially associated with significantly reduced operative time, blood loss, and chest tube duration in sleeve lobectomy, suggesting its potential utility for complex resections.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Li X, Li Q, Zhao E, et al. Perioperative Outcomes of Robotic- vs Video-Assisted Thoracoscopic Surgery in Non-Small Cell Lung Cancer After Neoadjuvant Therapy. Ann Thorac Surg. 2025. PMID: 41456828. doi:10.1016/j.athoracsur.2025.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。